Between @ and @ the Accord @ trial accrued @ patients with locally advanced rectal cancer and compared two different neoadjuvant chemoradiotherapies ( Capox @ : capecitabine + oxaliplatin +@ Gy vs Cap @ : capecitabine +@ Gy ) .